Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment crawled time : 12:07 save search
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
Published: 2021-03-11 (Crawled : 12:07) - investor.alkermes.com
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
|
| O: 1.56%
H: 1.79%
C: -0.1%
treatment fda drug designation
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Published: 2020-12-22 (Crawled : 12:07) - prnewswire.com
SNGX | $0.4 -1.43% -1.15% 410K
|
Health Technology
|
| O: -53.28%
H: 8.59%
C: 8.59%
cancer results phase 3 trial oral mucositis treatment topline
Spero Therapeutics Hosting Key Opinion Leader Call on Oral Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections
Published: 2020-09-24 (Crawled : 12:07) - globenewswire.com
SPRO | $1.435 2.14% 2.09% 120K
|
Health Technology
|
| O: -0.64%
H: 4.16%
C: 0.21%
treatment injection infections
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.